Building on approvals in the U.S. and EU, Bayer Healthcare said Japan has approved <a href="http://www.fiercepharma.com/tags/nexavar">Nexavar</a> to treat patients with unresectable differentiated thyroid carcinoma.
written on 20.06.2014